Content area
The functions of cilia—antenna-like organelles associated with a spectrum of disease states—are poorly understood, particularly in human cells. Here we show that human pluripotent stem cells (hPSCs) edited via CRISPR to knock out the kinesin-2 subunits KIF3A or KIF3B can be used to model ciliopathy phenotypes and to reveal ciliary functions at the tissue scale. KIF3A–/– and KIF3B–/– hPSCs lacked cilia, yet remained robustly self-renewing and pluripotent. Tissues and organoids derived from these hPSCs displayed phenotypes that recapitulated defective neurogenesis and nephrogenesis, polycystic kidney disease (PKD) and other features of the ciliopathy spectrum. We also show that human cilia mediate a critical switch in hedgehog signalling during organoid differentiation, and that they constitutively release extracellular vesicles containing signalling molecules associated with ciliopathy phenotypes. The capacity of KIF3A–/– and KIF3B–/– hPSCs to reveal endogenous mechanisms underlying complex ciliary phenotypes may facilitate the discovery of candidate therapeutics.
Tissues and organoids derived from human pluripotent stem cells with knocked-out kinesin-2 subunits lack cilia, and can be used to model ciliopathy phenotypes and to reveal underlying mechanisms of disease.
Details
; Reddy, Raghava 1 ; McFaline-Figueroa, José L 2
; Tran, Christine 1 ; Fu Hongxia 3 ; Freedman, Benjamin S 4
1 University of Washington School of Medicine, Division of Nephrology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); Kidney Research Institute, Seattle, USA (GRID:grid.34477.33); University of Washington School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
2 Columbia University, Department of Biomedical Engineering, New York, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
3 University of Washington School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Division of Hematology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Bioengineering (Adjunct), Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
4 University of Washington School of Medicine, Division of Nephrology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); Kidney Research Institute, Seattle, USA (GRID:grid.34477.33); University of Washington School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Bioengineering (Adjunct), Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Laboratory Medicine and Pathology (Adjunct), Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)